Inception Therapeutics is a multi-disciplinary discovery engine founded in 2011 with Versant Ventures to build and launch transformative new biotechnology companies. Inception’s integrated chemistry, biology and DMPK expertise and capabilities coupled with a successful track record have enabled Inception to become an established leader in new company creation.

Executive Leadership

Jeremy Caldwell photo

Jeremy Caldwell, Ph.D.
President and Chief Executive Officer

Richard Glynne photo

Richard Glynne, Ph.D.
Chief Scientific Officer

Scott Forrest photo

Scott Forrest, Ph.D.
Chief Operating Officer

Donna Tran photo

Donna Tran
Chief Financial Officer

Bryan Laffitte photo

Bryan Laffitte, Ph.D.
Vice President of Biology

Nick Stock photo

Nick Stock, Ph.D.
Vice President of Chemistry

Justin Ernst photo

Justin Ernst, Ph.D.
Executive Director of Chemistry

Lisa Rahbaek photo

Lisa Rahbaek, Ph.D.
Director of DMPK

Peppi Prasit photo

Peppi Prasit, Ph.D.
Scientific Advisor